Creative Planning’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-29,788
Closed -$883K 3037
2023
Q4
$883K Buy
29,788
+9,788
+49% +$195K ﹤0.01% 1302
2023
Q3
$317K Buy
20,000
+3,181
+19% +$52.9K ﹤0.01% 1889
2023
Q2
$317K Buy
+16,819
New +$199K ﹤0.01% 1867
2021
Q4
Sell
-279,963
Closed -$1.59M 2239
2021
Q3
$1.59M Buy
+279,963
New +$1.62M ﹤0.01% 757
2020
Q1
Sell
-28,786
Closed -$147K 2129
2019
Q4
$147K Buy
28,786
+15,662
+119% +$53.2K ﹤0.01% 1705
2019
Q3
$32K Sell
13,124
-1,173
-8% -$3.11K ﹤0.01% 1827
2019
Q2
$31K Sell
14,297
-55,937
-80% -$132K ﹤0.01% 1858
2019
Q1
$190K Buy
70,234
+33,736
+92% +$146K ﹤0.01% 1605
2018
Q4
$175K Buy
36,498
+12,298
+51% +$74.6K ﹤0.01% 1535
2018
Q3
$229K Buy
24,200
+19
+0.1% +$183 ﹤0.01% 1587
2018
Q2
$235K Buy
24,181
+11,589
+92% +$122K ﹤0.01% 1531
2018
Q1
$132K Sell
12,592
-5,158
-29% -$50.9K ﹤0.01% 1699
2017
Q4
$114K Sell
17,750
-18,000
-50% -$111K ﹤0.01% 1711
2017
Q3
$273K Buy
35,750
+17,638
+97% +$117K ﹤0.01% 1385
2017
Q2
$129K Sell
18,112
-35,332
-66% -$162K ﹤0.01% 1800
2017
Q1
$207K Buy
53,444
+28,744
+116% +$83.9K ﹤0.01% 1471
2016
Q4
$50K Sell
24,700
-2,718
-10% -$5.46K ﹤0.01% 2395
2016
Q3
$73K Buy
27,418
+9,142
+50% +$26.6K ﹤0.01% 2077
2016
Q2
$56K Buy
18,276
+671
+4% +$4.21K ﹤0.01% 2065
2016
Q1
$150K Buy
17,605
+1,158
+7% +$9.8K ﹤0.01% 1379
2015
Q4
$223K Sell
16,447
-1,168
-7% -$14.4K ﹤0.01% 1140
2015
Q3
$169K Buy
17,615
+2,696
+18% +$39.4K ﹤0.01% 1287
2015
Q2
$215K Buy
14,919
+619
+4% +$6.8K ﹤0.01% 853
2015
Q1
$128K Buy
14,300
+145
+1% +$1.05K ﹤0.01% 1443
2014
Q4
$86K Buy
14,155
+79
+0.6% +$722 ﹤0.01% 1625
2014
Q3
$149K Buy
14,076
+576
+4% +$6.51K ﹤0.01% 1235
2014
Q2
$160K Buy
13,500
+471
+4% +$5.91K ﹤0.01% 1155
2014
Q1
$195K Sell
13,029
-2,771
-18% -$43.7K ﹤0.01% 1013
2013
Q4
$232K Buy
15,800
+12,967
+458% +$199K ﹤0.01% 800
2013
Q3
$48K Hold
2,833
﹤0.01% 1540
2013
Q2
$47K Buy
+2,833
New +$45.9K ﹤0.01% 1423

Other funds holding IMGN

Creative Planning's IMGN Position: Q1 2024 in Review

Creative Planning sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 29,788 shares — an estimated $883K sold.

Creative Planning first reported a position in IMGN in Q2 2013 and held it in 31 quarters. The position peaked at $1.59M in Q3 2021. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Creative Planning reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Creative Planning sold 29,788 Immunogen Inc shares in Q1 2024, an estimated $883K.
  • Creative Planning first reported a position in Immunogen Inc in Q2 2013 and held it in 31 quarters.
  • Creative Planning's Immunogen Inc position peaked at $1.59M in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Creative Planning's 13F filing for Q1 2024, filed 13 May 2024.